Adris S - Search Results

1

Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells.

Ledda MF, Adris S, Bravo AI, Kairiyama C, Bover L, Chernajovsky Y, Mordoh J, Podhajcer OL. Ledda MF, et al. Among authors: adris s. Nat Med. 1997 Feb;3(2):171-6. doi: 10.1038/nm0297-171. Nat Med. 1997. PMID: 9018235

2

[The role of SPARC gene in tumorigenic capacity of human melanoma cells].

Ledda MF, Adris S, Bover L, Bravo AL, Mordoh J, Podhajcer OL. Ledda MF, et al. Among authors: adris s. Medicina (B Aires). 1996;56(1):51-4. Medicina (B Aires). 1996. PMID: 8734932 Spanish.

3

Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.

Ledda MF, Adris S, Bravo AI, Bover L, Carbone C, Paleolog E, Mordoh J, Chernajovsky Y, Podhajcer OL. Ledda MF, et al. Among authors: adris s. Cell Mol Biol (Noisy-le-grand). 1996 Jul;42(5):769-78. Cell Mol Biol (Noisy-le-grand). 1996. PMID: 8832108

4

The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma.

Ledda F, Bravo AI, Adris S, Bover L, Mordoh J, Podhajcer OL. Ledda F, et al. Among authors: adris s. J Invest Dermatol. 1997 Feb;108(2):210-4. doi: 10.1111/1523-1747.ep12334263. J Invest Dermatol. 1997. PMID: 9008236 Free article.

5

Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.

Berenstein M, Adris S, Ledda F, Wolfmann C, Medina J, Bravo A, Mordoh J, Chernajovsky Y, Podhajcer OL. Berenstein M, et al. Among authors: adris s. Cancer Gene Ther. 1999 Jul-Aug;6(4):358-66. doi: 10.1038/sj.cgt.7700056. Cancer Gene Ther. 1999. PMID: 10419054

6

IL-12 and IL-10 expression synergize to induce the immune-mediated eradication of established colon and mammary tumors and lung metastasis.

Lopez MV, Adris SK, Bravo AI, Chernajovsky Y, Podhajcer OL. Lopez MV, et al. Among authors: adris sk. J Immunol. 2005 Nov 1;175(9):5885-94. doi: 10.4049/jimmunol.175.9.5885. J Immunol. 2005. PMID: 16237081

7

[Antitumor gene therapy using suicide genes].

Berenstein M, Adris S, Ledda F, Wolfmann C, Medina J, Bravo A, Mordoh J, Chernajovsky Y, Podhajcer OL. Berenstein M, et al. Among authors: adris s. Medicina (B Aires). 1998;58(2):185-8. Medicina (B Aires). 1998. PMID: 9706253 Spanish.

8

IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response.

Adris S, Klein S, Jasnis M, Chuluyan E, Ledda M, Bravo A, Carbone C, Chernajovsky Y, Podhajcer O. Adris S, et al. Gene Ther. 1999 Oct;6(10):1705-12. doi: 10.1038/sj.gt.3301012. Gene Ther. 1999. PMID: 10516719

9

Mice vaccination with interleukin 12-transduced colon cancer cells potentiates rejection of syngeneic non-organ-related tumor cells.

Adris S, Chuluyan E, Bravo A, Berenstein M, Klein S, Jasnis M, Carbone C, Chernajovsky Y, Podhajcer OL. Adris S, et al. Cancer Res. 2000 Dec 1;60(23):6696-703. Cancer Res. 2000. PMID: 11118055

10

Hippocampal upregulation of the cyclooxygenase-2 gene following neonatal clomipramine treatment (a model of depression).

Cassano P, Hidalgo A, Burgos V, Adris S, Argibay P. Cassano P, et al. Among authors: adris s. Pharmacogenomics J. 2006 Nov-Dec;6(6):381-7. doi: 10.1038/sj.tpj.6500385. Epub 2006 Mar 28. Pharmacogenomics J. 2006. PMID: 16568149

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters